Sepracor Joins AARC Corporate Partner Program

New Collaboration Helps Respiratory Therapists Provide Patients With Best Care Possible

For Immediate Release

DALLAS (November 6, 2003) – The American Association for Respiratory Care (AARC) today announced the addition of Sepracor to its corporate sponsorship program directed to assisting respiratory therapists in providing top-quality care to their patients.   Sepracor is widely recognized in the respiratory care category as the makers of XOPENEX® (levalbuterol HCl) inhalation solution for the treatment or prevention of bronchospasm in patients 6 years of age and older with reversible obstructive airway disease, such as asthma.

This alliance will create materials and information that enable respiratory therapists to better meet the special needs of   patients with asthma, chronic obstructive pulmonary disease, cystic fibrosis, and other respiratory problems.   Above and beyond providing professional support and education, AARC also has the potential to help its corporate partners in the research and development of their cutting-edge technologies and pharmaceuticals.

“As the only professional association for respiratory therapists, we stand singularly committed to addressing their special needs in providing top-quality care,” said Kevin Shrake, MA, RRT, FAARC, AARC's Chief Operating Officer. “Sepracor is significantly supporting this goal through its resources and we anticipate making great strides in the coming year.”

Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease through the discovery, development, and commercialization of innovative pharmaceutical products that are directed toward serving unmet medical needs. Sepracor's drug development program has yielded an extensive portfolio of pharmaceutical compound candidates, including candidates for the treatment of respiratory, urology, and central nervous system disorders. Sepracor's corporate headquarters are located in Marlborough, MA.

The American Association for Respiratory care, the only professional membership association for respiratory therapists, focuses primarily on respiratory therapy education and research. Its goals are to ensure that respiratory patients receive safe and effective care from qualified professionals and to benefit respiratory health care providers. The Association continues to advocate, on behalf of pulmonary patients, for appropriate access to respiratory services provided by qualified professionals.

# # #

AARC Contact:
Sherry Milligan
Communications Manager
972-406-4656,